Bioactivation and inactivation of aflatoxin B1 by human, mouse and rat liver preparations: Effect on SCE in human mononuclear leucocytes
- 3 February 1997
- journal article
- Published by Elsevier BV in Mutation research. Reviews in mutation research
- Vol. 373 (2), 257-264
- https://doi.org/10.1016/s0027-5107(96)00205-9
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- N-Hydroxylation of dapsone by multiple enzymes of cytochrome P450: implications for inhibition of haemotoxicity.British Journal of Clinical Pharmacology, 1995
- Kinetic parameters of lymphocyte microsomal epoxide hydrolase in carbamazepine hypersensitive patients: Assessment by radiometric HPLCBiochemical Pharmacology, 1995
- Evaluation of the generation of genotoxic and cytotoxic metabolites of benzo[a]pyrene, aflatoxin B1, naphthalene and tamoxifen using human liver microsomes and human lymphocytesHuman & Experimental Toxicology, 1995
- Correlation between trans-stilbene oxide-glutathione conjugation activity and the deletion mutation in the glutathione S-transferase class Mu gene detected by polymerase chain reactionBiochemical Pharmacology, 1992
- Species Differences in Metabolism and Pharmacokinetics: Are We Close to an Understanding?Drug Metabolism Reviews, 1991
- An in vitro study of the microsomal metabolism and cellular toxicity of phenytoin, sorbinil and mianserin.British Journal of Clinical Pharmacology, 1988
- Aflatoxin exposure, hepatitis b virus infection and liver cancer in swazilandInternational Journal of Cancer, 1987
- A Case-Control Dietary Study of Primary Liver Cancer Risk from Aflatoxin Exposure*International Journal of Epidemiology, 1982
- Dietary aflatoxins and liver cancer – a population based study in KenyaBritish Journal of Cancer, 1973
- On mechanisms affecting species susceptibility to aflatoxinBiochimica et Biophysica Acta (BBA) - General Subjects, 1970